We Think Oxford Nanopore Technologies (LON:ONT) Can Afford To Drive Business Growth
Mar 31
Have your own idea? Try our Stock Screener
U.K. (FTSE) Clinical Research and Equipment Industry Analysis
UpdatedApr 05, 2026
DataAggregated Company Financials
Companies7
- 7D5.1%
- 3M-6.0%
- 1Y10.3%
- YTDn/a
The Clinical Research and Equipment industry is up 5.1% in the last week, with Oxford Nanopore Technologies up 5.5%. In the last 12 months, the industry was up 10%. As for the next few years, earnings are expected to grow by 54% per annum.
Industry Valuation and Performance
Has the U.K. Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 05 Apr 2026 | UK£1.4b | UK£323.0m | -UK£156,192,254.00 | 8.2x | -8.8x | 4.2x |
| Tue, 03 Mar 2026 | UK£1.5b | UK£304.7m | -UK£159,511,254.00 | 10.9x | -9.5x | 5x |
| Thu, 29 Jan 2026 | UK£1.8b | UK£304.6m | -UK£159,441,254.00 | 7.7x | -11.3x | 5.9x |
| Sat, 27 Dec 2025 | UK£1.4b | UK£304.6m | -UK£159,441,254.00 | 8.8x | -9x | 4.7x |
| Mon, 24 Nov 2025 | UK£1.5b | UK£304.3m | -UK£163,156,254.00 | 7.5x | -9.2x | 4.9x |
| Wed, 22 Oct 2025 | UK£1.6b | UK£304.3m | -UK£163,156,254.00 | 9x | -9.7x | 5.2x |
| Fri, 19 Sep 2025 | UK£1.8b | UK£313.5m | -UK£158,190,352.00 | 6.2x | -11.3x | 5.7x |
| Sun, 17 Aug 2025 | UK£2.3b | UK£291.9m | -UK£160,968,352.00 | 6.5x | -14x | 7.7x |
| Tue, 15 Jul 2025 | UK£1.7b | UK£291.9m | -UK£160,968,352.00 | 6.4x | -10.3x | 5.7x |
| Thu, 12 Jun 2025 | UK£1.6b | UK£319.4m | -UK£190,810,117.60 | 7.6x | -8.4x | 5x |
| Sat, 10 May 2025 | UK£1.7b | UK£313.2m | -UK£192,933,253.70 | 11.2x | -8.7x | 5.4x |
| Mon, 07 Apr 2025 | UK£1.4b | UK£315.9m | -UK£186,638,286.55 | 5.7x | -7.7x | 4.5x |
| Wed, 05 Mar 2025 | UK£1.4b | UK£306.2m | -UK£195,386,130.24 | 6.7x | -7.3x | 4.6x |
| Fri, 31 Jan 2025 | UK£2.0b | UK£306.9m | -UK£195,547,507.20 | 7.4x | -10.4x | 6.6x |
| Sun, 29 Dec 2024 | UK£1.8b | UK£306.6m | -UK£195,250,541.04 | 7.6x | -9.4x | 6x |
| Tue, 26 Nov 2024 | UK£1.9b | UK£306.6m | -UK£193,104,295.28 | 7.8x | -9.6x | 6.1x |
| Thu, 24 Oct 2024 | UK£2.0b | UK£304.8m | -UK£192,626,890.90 | 11.2x | -10.5x | 6.7x |
| Sat, 21 Sep 2024 | UK£2.2b | UK£303.8m | -UK£191,679,415.50 | 11.5x | -11.5x | 7.3x |
| Mon, 19 Aug 2024 | UK£1.9b | UK£296.2m | -UK£188,767,577.70 | 12.3x | -9.9x | 6.3x |
| Wed, 17 Jul 2024 | UK£1.7b | UK£295.1m | -UK£189,581,540.91 | 11.8x | -8.7x | 5.6x |
| Fri, 14 Jun 2024 | UK£1.6b | UK£295.5m | -UK£189,761,016.45 | 11.7x | -8.5x | 5.5x |
| Sun, 12 May 2024 | UK£1.7b | UK£295.1m | -UK£187,865,864.75 | 6797.2x | -8.9x | 5.6x |
| Tue, 09 Apr 2024 | UK£1.7b | UK£319.0m | -UK£191,315,873.91 | 69.6x | -8.7x | 5.2x |
| Thu, 07 Mar 2024 | UK£1.8b | UK£285.6m | -UK£189,049,492.55 | 6894x | -9.7x | 6.4x |
| Sat, 03 Feb 2024 | UK£2.8b | UK£450.4m | -UK£176,742,955.00 | 69.8x | -16x | 6.3x |
| Mon, 01 Jan 2024 | UK£3.2b | UK£449.9m | -UK£173,922,769.00 | 56.2x | -18.3x | 7.1x |
| Wed, 29 Nov 2023 | UK£3.0b | UK£455.2m | -UK£168,271,664.00 | 49.9x | -18x | 6.7x |
| Fri, 27 Oct 2023 | UK£2.9b | UK£458.8m | -UK£165,751,401.00 | 46.7x | -17.6x | 6.3x |
| Sun, 24 Sep 2023 | UK£3.1b | UK£447.9m | -UK£167,427,280.00 | 67.5x | -18.3x | 6.8x |
| Tue, 22 Aug 2023 | UK£3.1b | UK£476.1m | -UK£126,481,538.00 | 70.6x | -24.3x | 6.4x |
| Thu, 20 Jul 2023 | UK£3.3b | UK£476.1m | -UK£124,419,656.00 | 69.6x | -26.4x | 6.9x |
| Sat, 17 Jun 2023 | UK£3.1b | UK£476.3m | -UK£124,569,758.00 | 64.4x | -24.5x | 6.4x |
| Mon, 15 May 2023 | UK£3.2b | UK£477.9m | -UK£122,813,020.00 | 36.7x | -26x | 6.7x |
| Wed, 12 Apr 2023 | UK£3.0b | UK£458.8m | -UK£118,927,081.00 | 33x | -25.4x | 6.6x |
Price to Earnings Ratio
-25.4x
Current Industry PE
- Investors are pessimistic on the British Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 6.0x is higher than the industry's current PS ratio of 4.2x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
- Revenues have also declined 11% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Comparison
How does U.K. Clinical Research and Equipment compare with similar industries?
| GB Market | 4.54% | |
| Healthcare | 5.69% | |
| Life Sciences | 5.08% | |
| Clinical Research and Equipment | 5.08% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ONT Oxford Nanopore Technologies | UK£1.20 | 5.5% +UK£61.2m | 14.7% | PS5.2x | |
| DXRX Diaceutics | UK£1.55 | 5.8% +UK£6.8m | 37.3% | PS3.8x |
